Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Biocon Biologics Ltd BBL a fully integrated global biosimilars company and subsidiary of Biocon Ltd today announced that the European Commission EC has granted marketing authorisation in the European
Follitropin delta starting dose of micrograms gday has comparable efficacy and safety as a starting dose of International Units IUday of follitropin alfa for ovarian stimulation in IVFICSI GnRH antagonist protocol cycles
Stallergenes Greer Shionogi Co Ltdand CEOLIA Pharma Co Ltd CEOLIA today announced the transition of promotional activities for Actair in Japan Actair is Stallergenes Greers sublingual immunotherapy
Biopharmaceutical hightech company InnoCare Pharma announced today that its independently developed novel ADC innovative drug ICPB targeting BH has been approved by the Center for Drug Evaluation
Akeso Inc HK Akeso or the Company has announced the successful enrollment of the first patient in its Phase Ia clinical trial for AKD a bispecific AntibodyDrug Conjugate ADC targeting Trop and Nectin
Brii Biosciences Limited a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet medical needs today announced that it has entered into a license and technology
Neurizon Therapeutics Limited a clinicalstage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases is pleased to announce it has executed an exclusive global license
BioVersys AG a multiasset clinical stage biopharmaceutical company focusing on research and development of novel antibacterial products for serious lifethreatening infections caused by multidrugresistant MDR bacteria
MaaT Pharma a clinicalstage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM MET dedicated to enhancing survival for patients with cancer through immune modulation
Gwo Xi Stem Cell Applied Technology Co Ltd TPEx is a clinicalstage cell therapy company headquartered in Hsinchu Taiwan advancing mesenchymal stem cell MSCs therapies Leveraging its patented technologies
